This federal contract award is for $1,760.41 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has a completion date of December 12, 2024 and does not have a set-aside designation, indicating open competition. As a major supplier of medical commodities to federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, AmerisourceBergen plays a critical role in ensuring the availability of essential pharmaceutical and medical products for the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/12/25, 9:45 AM